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Background: Adult cardiac surgery is significantly associated with the development of acute kidney injury (AKI).
Still, the incidence and outcomes of AKI vary according to its definition. Our retrospective monocentric study
comparatively investigates the yield of RIFLE definition, which is based on the elevation of serum creatinine levels
(SCr) or the reduction of urine output (UO), taking into account only one or both criteria. Pre- and per-operative
risk factors for post-operative AKI were evaluated.
Methods: All adult patients undergoing cardiac surgery, with or without cardiopulmonary bypass, from April 2008
to March 2009 were included. Clinical, biological and surgical features were recorded. Baseline serum creatinine was
determined as its value on day 7 before surgery. Post-operative AKI was diagnosed and scored based upon the
highest serum creatinine and/or the lowest urine output.
Results: 443 patients (Male/Female ratio, 2.3; median age, 69y) were included, with 221 (49.9 %) developing
postoperative AKI. Elevated serum creatinine (AKISCr) and oliguria (AKIUO) was observed in 9.7 % and 40.2 %,
respectively. AKI patients had a significantly higher BMI and baseline SCr. In comparison to AKIUO, AKISCr mostly
occurred in patients with co-morbidities, and was associated with an increased mortality at 1-year post surgery.
Conclusions: The use of standard RIFLE definition of AKI in a cohort of 443 patients undergoing cardiac surgery
resulted in an incidence reaching 50 %. Still, significant discrepancies were found between AKISCr and AKIUO
regarding the incidence and outcomes. In line with previous reports, our data questions the utility of urine output
as a criterion for AKI diagnosis and management after cardiac surgery.
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Adult cardiac surgery, with or without cardiopulmonary
bypass (CPB), remains significantly associated with acute
kidney injury (AKI). The incidence of post-surgery AKI
varies from 5 to 42 % according to recent studies [1, 2].
In order to properly assess and compare the incidence
and outcomes of AKI worldwide, the Acute Dialysis Qual-
ity Initiative Group proposed in 2004 a standard classifica-
tion termed “RIFLE”, which stands for the acronym “Risk,* Correspondence: francois.jouret@chu.ulg.ac.be
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ney disease”, and is based on 2 criteria: serum creatinine
levels (SCr) and urine output (UO) [3]. The main objec-
tives of the present retrospective monocentric study were
to (i) evaluate the incidence of AKI following cardiac sur-
gery using the conventional RIFLE classification, and (ii)
compare the yield of either RIFLE criteria to identify the
patients developing AKI during the postoperative period.
Next, we assessed the impact of AKI defined using either
the full RIFLE classification or only one of either criter-
ion on the length of in-ICU (intensive care unit) and in-
hospital stays and on mortality at 1 year. Finally, weThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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post-operative AKI in our cohort.
Method
Patients
The present retrospective study was approved by the
University Hospital of Liège Ethical Board (Ref. B7072
0108229). Data were collected from the database of
University of Liège Hospital, and encompassed all adult
patients who underwent heart surgery, including on-
and off-pump coronary bypass grafting (CABG), isolated
aortic or mitral valve reparation/replacement, or com-
bined surgery (valve + CABG), from April 2008 to March
2009. Eight patients under chronic haemodialysis prior
to surgery were excluded.
Types of anaesthesia and surgery
Anaesthesia was classically performed through target-
controlled infusions of propofol and remifentanil. Tran-
examic acid was used as antifibrinolytic agent (2.5 g
injected prior to the start of surgery and 2.5 g injected at
the end of CPB). The volume of priming was 1600 mL
consisting of 150 mL of Mannitol® 15 % and 1450 mL of
Volulyte® 6 %, 1 g of tranexamic acid, as well as 5000 IU
of unfractioned heparine. Minimal haemodilution level
was 20 % haematocrit. Standard cannulation was carried
out (i.e. into the ascending aorta for reinjection and sin-
gle cannulation of the right auricle for On-pump CABG
and aortic valve surgery, double venous cannulation for
mitral valve surgery). CPB (roller pump) was initiated to
maintain a flow between 2.4 L/m2/min and 3.2 L/m2/
min. Most interventions were conducted using normo-
thermia, with intermittent cold crystalloid cardioplegia.
Blood discharged from the left ventricle was collected in
the venous reservoir of the CPB. The pericardial blood
was suctioned in a separate reservoir, treated through an
autologous transfusion system and re-transfused into the
CPB circuit or directly to the patient after neutralisation
of heparin for On-pump CABG. For isolated valve or
combined surgery, the pericardial blood was re-infused
to the CPB’s venous reservoir.
Clinical and biological variables
The following variables were analysed: gender (male vs
female), age (years), body mass index (BMI, kg/m2), pres-
ence of high blood pressure (arterial pressure ≥140/
90 mmHg) and/or treatment for high blood pressure (yes
vs no), history of chronic obstructive pulmonary disease
(COPD, yes vs no), angina pectoris (absence vs presence),
myocardial infarction prior surgical intervention (yes vs
no), diabetes mellitus (DM, yes vs no), emergency surgery
(yes vs no), preoperative glomerular filtration rate (GFR,
mL/min) and hemoglobin (g/dL), left ventricular ejection
fraction < 60 % (LVEF < 60 %, yes vs no), surgical delay(days between the diagnostic coronarography and surgical
intervention), type of operation (off-pump CABG, on-
pump CABG, isolated valve, combined surgery), duration
of aortic clamping (minutes), duration of CPB (minutes),
nadir hematocrit during CPB and nadir mean arterial
pressure (MAP, mmHg) during surgery. For each patient,
the mortality scores (Parsonnet [4], EuroSCORE1 [5])
were calculated. In-ICU and in-hospital lengths of stay,
as well as in-hospital mortality rates, were considered.
Patients’ 1-year survival rate was established on the
basis of post-operative follow-up and/or phone contact.
Assessment of renal function at baseline and after surgery
Baseline serum creatinine levels were systematically ob-
tained at the time of the preoperative consultation in
Anaesthesiology (i.e. 7 days before surgery) and mea-
sured by the isotope dilution mass spectrometry trace-
able Jaffe method from Roche®. GFR was estimated using
the Modification of the Diet in Renal Disease (MDRD)
formula. Following surgery, AKI was diagnosed within
the first 7 days post-surgery. Severity of AKI according
to the RIFLE classification was established by using the
highest serum creatinine level and/or the lowest urine
output. Stages L and E of the RIFLE classification, i.e.
complete loss of renal function > 4 weeks or > 3 months,
respectively, were not included in the analysis. The man-
agement of patients, including the use of diuretics and
renal replacement therapy (RRT), was at the discretion
of the physicians in charge.
Statistics
Results were expressed as median and inter-quartile ranges
(IQR) and as counts and proportions (%) for qualitative
variables. Non parametric Kruskal-Wallis and Wilcoxon
tests were used for comparing samples from different
groups. Proportions were compared using the chi-squared
test for contingency tables. The relationship between pa-
tients’ postoperative renal status and a set of covariates was
tested using binary logistic regression analysis. Results were
expressed in terms of the odds ratio (OR) together with its
95 % CI. Survival data were illustrated using the Kaplan-
Meier method, with the Cox proportional hazard (PH)
model used to assess the effect of covariates on survival.
All results were considered to be significant at the 5 % crit-
ical level (p < 0.05). Data analysis was carried out using,
Satistica (version 10), SAS (version 9.3 for Windows) and
S-PLUS (version 8.1) statistical softwares.
Results
Characteristics of the cohort
On the basis of the selection criteria, 443 patients were
included during the study period. Baseline demographic,
clinical, biological and operative characteristics of this
cohort are summarized in Table 1. Proportion of male
Table 1 Baseline, clinical and operative characteristics (N = 443)
Variable
Age (years) 69.0 (60.0 - 76.0)
Gender (Female) (%) 133 (30.0)
BMI (kg/m2) 26.2 (23.7 - 29.4)
Hypertension (%) 351 (81.0)
COPD (%) 84 (19.0)
Angina pectoris (%) 197 (44.5)
Myocardial infarction previous surgery (%) 116 (26.2)
Diabete mellitus (%) 100 (22.6)
Emergency (%) 12 (2.70)
Preoperative GFR (mL/min) 78.0 (64.0 - 92.0)
Preoperative hemoglobin (g/dL) 13.9 (12.6 - 14.8)
LVEF < 60 % (%) 114 (25.7)
Logistic Parsonnet (%) 6.30 (3.10 - 13.6)
Logistic EuroSCORE1 (%) 4.00 (2.10 - 7.50)
Surgical delay (days) 21.0 (7.00 - 42.0)
Type of surgery:
OPCABG (%) 58 (13.1)
CABG (%) 182 (41.1)
Valve surgery (%) 148 (33.4)
Valve and CABG (%) 55 (12.4)
CPB time (min.)* 87.0 (73.0 - 104.0)
Aortic cross clamp time (min.)* 55.0 (41.0 - 69.0)
Nadir hematocrit (%) 21.0 (19.0 - 24.0)
Nadir MAP during surgery (mmHg) 45.0 (40.0 - 55.0)
Days in ICU 2.0 (2 - 4)
Days in hospital 12.0 (10 - 18)
Data are expressed as median (25-75th percentiles) or proportion of patients
in %
*Data are calculated as median (25-75th percentiles) only for cases with
cardiopulmonary bypass (n = 385)
BMI: body mass index; COPD: chronic obstructive pulmonary disease; GFR:
glomerular filtration rate; LVEF: left ventricular ejection fraction; surgical delay:
delay between diagnostic coronarography and surgery; OPCABG: off-pump
coronary bypass graft; CABG: coronary artery bypass graft with cardiopulmonary
bypass; Valve surgery: aortic valve replacement or mitral valve repair/replacement
surgery; Valve and CABG: aortic valve replacement or mitral valve repair/
replacement surgery combined with coronary artery bypass graft; CPB:
cardiopulmonary bypass; MAP: mean arterial pressure.*: n = 385; ICU: intensive
care unit
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69 years [60–76]. Preoperative diagnostic of hyperten-
sion was present in 81.0 % of the patients. Most patients
(76.7 %) had a normal renal function before surgery. Pa-
tients presenting with preoperative chronic kidney disease
(CKD) were significantly older than individuals with
normal kidney function (74-y vs 66-y, p = 0.0001), and
included a higher proportion of females (41.7 % vs
26.5 %, p < 0.0001). The median mortality risks assessed
by Parsonnet and EuroSCORE1 scores were 6.30 (3.10-
13.6) and 4.00 (2.10-7.50), respectively, for the entirecohort. Two hundred and forty patients (54.2 %) were
operated by CABG alone and 58 (13.1 %) of them were
off-pump procedures.Incidence of AKI post cardiac surgery using combined or
isolated criteria of the RIFLE classfication
Among the cohort of 443 patients, 221 (49.9 %) devel-
oped AKI within the week following surgery according
to the conventional RIFLE classification. Eighty patients
(36.2 %) reached stage RISK, 114 (51.6 %) stage INJURY
and 27 (12.2 %) stage FAILURE. Stages L and E of the
RIFLE classification were not included in our analysis.
Of note, no patient actually reached L and E stages. Table 2
summarizes the clinical and operative features of the pa-
tients with or without postoperative AKI. Patients devel-
oping AKI were significantly older and heavier, with a
lower preoperative GFR than non-AKI patients. Their lo-
gistic Parsonnet and EuroSCORE1 scores, as well as their
program of surgery, were significantly worse. Of note, 8
patients (1.08 % of the cohort) required renal replace-
ment therapy (RRT). Only 2 of them recovered normal
renal function, while the other 6 died during their in-
hospital stay.
The RIFLE criterion SCr only identified 9.7 % of pa-
tients developing postoperative AKI, whereas the UO
criterion diagnosed AKI in 40.2 % of cases (Table 2). Pa-
tients developing AKIUO presented a significantly lower
rate of preoperative hypertension (p < 0.001) and COPD
(p < 0.05) than patients developing AKISCr. Preoperative
GFR and hemoglobin levels were higher in the AKIUO
than AKISCr patients. The delay between cardiologic ex-
ploration and heart surgery was also significantly longer
in the AKIUO group (p < 0.05).Influence of AKI definition on the length of in-hospital
and ICU stays and mortality
On the basis of the full RIFLE classification, the duration
of the ICU stay was shorter for patients who did not
develop AKI after surgery than for AKI patients (2 [2 - 3]
vs 3 [2 - 4] days; p < 0.001). However, no significant dif-
ference was observed regarding the length of in-hospital
stay. The ICU period significantly increased with the
degree of AKI severity based on the RIFLE stages: 2.0
(2–3) days for AKI RISK (n = 80), 3.0 (2 - 5) days for AKI
INJURY (n = 114), and 5.0 (3 - 12) days for AKI FAILURE
(n = 27); p < 0.001. When comparing either criterion of
the RIFLE classification as the sole indicator of AKI, the
duration of ICU stay tended to be slightly longer in AKISCr
as compared to AKIUO (3.0 [2 - 6] vs 3.0 [2 - 4]; p = 0.07).
Concerning mortality, 14 patients (3.16 %) died during
their in-hospital stay. Causes of in-hospital mortality were:
cardiogenic shock (n = 5), sepsis (n = 4), hemorrhagic shock
(n = 3), stroke (n = 1), and aortic dissection (n = 1).
Table 2 Distribution of preoperative and operative data according to occurence or not of AKI allocated to RIFLE (Risk, Injury and
Failure grade) and by the serum creatinine (SCr) or urine output (UO) criteria AKI
Variable No AKI AKI p-value AKI SCr AKI UO p-value
(N = 222) (N = 221) (N = 43) (N = 178)
Age (years) 65.0 (59.0 - 74.0) 71.0 (63.0 - 73.0) < 0.001 71.0 (60.0 - 77.0) 71.0 (63.0 - 77.0) 0.98
Gender (Female) (%) 61 (27.5) 72 (32.5) 0.21 12 (27.9) 60 (33.7) 0.47
BMI (kg/m²) 25.6 (22.9 - 28.3) 26.9 (24.3 - 30.5) < 0.001 28.3 (24.8 - 30.9) 26.6 (24.4 - 30.4) 0.25
Hypertension (%) 178 (80.2) 173 (78.3) 0.62 40 (93.0) 133 (74.7) < 0.001
COPD (%) 39 (17.6) 45 (20.4) 0.45 14 (32.6) 31 (17.4) 0.03
Angina pectoris (%) 106 (47.7) 91 (41.2) 0.16 16 (37.2) 75 (42.1) 0.55
MI previous surgery (%) 67 (30.2) 49 (22.2) 0.06 10 (23.3) 39 (21.9) 0.85
Diabetes mellitus (%) 44 (19.8) 56 (25.3) 0.16 14 (32.6) 42 (23.6) 0.22
Emergency (%) 8 (3.60) 4 (1.81) 0.24 0 (0.00) 4 (2.25) 0.32
Preoperative GFR
(mL/min) 83.0 (73 - 97) 72.0 (56 - 89) < 0.001 67.0 (49 - 78) 73.5 (56 - 89) 0.06
Preoperative
Hemoglobin (g/dL) 14.0 (12.7 - 14.9) 13.5 (12.4 - 14.7) 0.10 12.9 (11.5 - 14.6) 13.8 (12.5 - 14.8) 0.06
LVEF < 60% (%) 58 (26.1) 56 (25.3) 0.85 13 (30.2) 43 (24.2) 0.41
Logistic
Parsonnet (%) 5.12 (2.65 - 10.8) 7.60 (4.05 - 17.3) < 0.001 8.41 (5.16 - 15.9) 7.47 (4.00 - 18.7) 0.71
Logistic
EuroSCORE1 (%) 3.51 (2.01 - 6.48) 4.79 (2.28 - 8.58) 0.004 5.29 (2.73 - 11.0) 4.65 (2.21 - 8.44) 0.40
Surgical delay (days) 20.0 (6 - 39) 22.0 (8 - 45) 0.18 17.0 (5 - 35) 27.0 (8 - 48) 0.02
Type of surgery
OPCABG (%) 37 (16.7) 21 (9.50) < 0.001 6 (14.0) 15 (8.43) 0.13
CABG (%) 102 (45.9) 80 (36.1) 13 (30.2) 67 (37.6)
Valve surgery (%) 74 (33.3) 74 (33.5) 19 (44.2) 55 (30.9)
Valve and CABG (%) 9 (4.05) 46 (20.8) 5 (11.6) 41 (23.0)
CPB time (min.)* 85.0 (70 - 100) 90.0 (75.5 - 108.0) 0.02 89.0 (81.0 - 100.0) 90.0 (74.0 - 109.0) 0.80
Aortic cross
Clamp time (min.)* 52.0 (39.0 - 64.0) 58.0 (44.0 - 75.0) 0.003 58.0 (45.0 - 71.0) 58.5 (43.5 - 76.0) 0.83
Nadir hematocrit (%) 22.0 (19 - 24) 20.0 (19 - 24) 0.06 20.0 (19.0 - 24.0) 20.0 (19.0 - 24.0) 0.83
Nadir MAP
During surgery (mmHg) 45 (40 -55) 45 (40 -55) 0.57 45 (40 -55) 45 (40 -50) 0.50
Days in ICU 2.0 (2 - 3) 2.0 (2 -4) < 0.001 3.0 (2 - 6) 2.0 (2 - 4) 0.07
Days in hospital 12.0 (10 - 16) 13.0 (10 - 18) 0.55 14.0 (11 - 22) 12.0 (10 - 18) 0.07
Data are expressed as median (25-75th percentiles) or proportion of patients in %
*Data are calculated as median (25-75th percentiles) only for cases with cardiopulmonary bypass (n = 385)
BMI: body mass index; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; GFR: glomerular filtration rate; LVEF: left ventricular ejection
fraction; Surgical delay: delay between diagnostic coronarography and surgery; OPCABG: off-pump coronary artery bypass graft; CABG: Coronary artery bypass
graft with cardiopulmonary bypass; Valve surgery: aortic valve replacement or mitral valve repair/replacement surgery; Valve and CABG: aortic valve replacement or
mitral valve repair/replacement surgery combined with coronary artery bypass graft; CPB: cardiopulmonary bypass; MAP: mean arterial pressure; ICU: intensive
care unit
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for 364 patients of the cohort (82.2 %), and a sum of 20
deceased patients was recorded. Preoperative characteris-
tics which were significantly associated with an increased
risk for 1-year mortality included: age, COPD, CKD,
anaemia, LEVF < 60 % and surgical delay (Table 3). Thecomplexity of surgery, including the nadir of per-operative
haematocrit, was also identified as a significant risk factor
for death at 1-year post cardiac surgery. Postoperative AKI
was also associated with an increased risk for 1-year
mortality (p < 0.05, Table 3), which was further accentu-
ated upon AKI severity score (p < 0.01, Fig. 1). One-year
Table 3 Distribution of preoperative and operative data according to status (death or alive) at one year after surgery
Variable Death Alive p-value
(N = 20) (N = 344)
Age (years) 77.0 (69.5 - 79.5) 68.5 (60.0 - 75.0) 0.004
Gender (Female) (%) 9 (45.0) 94 (27.3) 0.89
BMI (kg/m2) 24.5 (22.6 - 27.9) 26.2 (23.6 - 29.3) 0.28
Hypertension (%) 7 (35.0) 56 (16.3) 0.74
COPD (%) 7 (35.0) 56 (16.3) 0.03
Angina pectoris (%) 9 (45.0) 149 (43.3) 0.88
MI previous surgery (%) 3 (15.0) 87 (25.3) 0.30
Diabetes (%) 4 (20.0) 80 (23.3) 0.74
Emergency (%) 1 (5.00) 8 (2.33) 0.45
Preoperative GFR (mL/min) 60.0 (43.0 - 75.0) 79.5 (65.0 - 93.0) 0.002
Preoperative hemoglobin (g/dL) 11.4 (9.9 - 13.0) 13.9 (12.6 - 14.9) < 0.001
LVEF < 60 % 10 (50.0) 82 (23.9) 0.008
Surgical delay (days) 14.0 (4.0 - 19.0) 22.0 (8.0 - 45.0) 0.008
Type of surgery
OPCABG (%) 1 (5.00) 42 (12.2) 0.41
CABG (%) 6 (30.0) 142 (41.3)
Valve surgery (%) 9 (45.0) 116 (33.7)
Valve and CABG (%) 4 (20.0) 44 (12.8)
CPB time (min.)* 89.5 (79.0 - 110.0) 85.0 (66.5 - 102.5) 0.19
Aortic cross clamp time (min.)* 59.5 (44.5 - 78.0) 51.0 (35.0 - 67.0) 0.13
Nadir hematocrit (%) 19.0 (18.0 -19.0) 21.0 (19.0 - 24.0) < 0.001
Nadir MAP during surgery (mmHg) 45.0 (40–53) 45.0 (40–55) 0.68
Postoperative AKI (%) 15 (75.0) 175 (50.9) 0.04
Data are expressed as median (25-75th percentiles) or proportion of patients in %
*Data are calculated as median (25-75th percentiles) only for cases with cardiopulmonary bypass (n=385)
BMI: body mass index; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; GFR: glomerular filtration rate; LVEF: left ventricular ejection
fraction; Surgical delay: delay between diagnostic coronarography and surgery; OBCABG: off-pump coronary artery bypass graft; CABG: Coronary artery bypass
graft with cardiopulmonary bypass; Valve surgery: aortic valve replacement or mitral valve repair/replacement surgery; Valve and CABG: aortic valve replacement or
mitral valve repair/replacement surgery combined with coronary artery bypass graft; CPB: cardiopulmonary bypass; MAP: mean arterial pressure
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in comparison to AKIUO group (p < 0.05, Fig. 2).
Predictive pre- and per-operative risk factors for AKI
In univariate analysis adjusted for preoperative CKD, six
variables were positively associated with the occurrence of
AKI defined upon the conventional RIFLE classification:
age (OR = 1.02 [IC95 % 1.01-1.04], p = 0.016), BMI (OR =
1.08 [IC95 % 1.03-1.13], p = 0.001), logistical Parsonnet
score (OR = 1.05 [IC95 % 1.03-1.09], p < 0.0001), combined
surgery (OR = 6.26 [IC95 % 2.88-13.6], p < 0.0001), duration
of aortic clamping (OR = 1.01 [IC95 % 1.01-1.02], p = 0.007)
and duration of CPB (OR = 1.02 [IC95 % 1.01-1.03], p =
0.001). In multivariate setting, the occurrence of AKI in-
creased with BMI (OR = 1.12 [IC95 1.06-1.18], p < 0.001),
the type of surgery (combined surgery (OR = 10.03 [IC95:
3.11-33.9], p < 0.001)), and the lower preoperative GFR
(OR = 0.98 [IC95: 0.97-0.99], p = 0.004) (Table 4).Discussion
The present retrospective monocentric study includes
443 patients undergoing elective or emergent cardiac
surgery, and investigates the incidence and outcomes of
postoperative AKI, as well as the pre- and per-operative
risk factors for AKI. The incidence and outcomes of AKI
vary according to its definition. In the present study, we
first used the conventional 2004 RIFLE classification
which is based on the elevation of SCr and the decrease
of UO [6]. This classification has been approved for cardiac
surgery [1, 7–9]. In an original approach, we compared
AKI incidence and outcomes according to SCr or UO cri-
teria. We observed a 7-day incidence of AKI reaching 50 %
by taking into account both RIFLE criteria. This percentage
of postoperative AKI is rather high, as compared to previ-
ous reports. This may be partly explained by the use of all
daily values of SCr and UO for each patient over the 7-day
period following surgery. In a similar retrospective study,






















Fig. 1 Survival post cardiac surgery according to acute kidney injury severity. Kaplan-Meier survival curve post cardiac surgery in patients with
increasing RIFLE stages of acute kidney injury on the basis of elevated serum creatinine (SCr) or decreased urine output (UO)
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AKI of 23.5 % [7]. These authors only tracked the single
variation in SCr during the length of hospitalisation. Con-
versely, by using the complete RIFLE classification, Hobson
et al. reported an incidence of AKI reaching 43.0 % after
cardiac surgery, which corresponds with our observations
[1]. Interestingly, each component of RIFLE, i.e. SCr or
UO, differentially contributes to AKI incidence and out-
comes, as previously illustrated by McIlroy et al. [10] andDeath  














Fig. 2 Survival post cardiac surgery according to AKI status. Kaplan-Meier s
injury (AKI, blue line), AKI with elevated serum creatinine (SCr, dotted red liWlodzimirow, et al. [11]. In our series, the elevation of SCr
was observed in 9.7 %, whereas a decreased UO was noted
in 40.2 %. Such a 4-fold increase in AKI incidence when
the UO criterion is taken into account provides cause for
concern regarding its validity and the true significance of
diagnosed AKIUO. To apply the SCr criteria of RIFLE, in-
formation on prior renal function is needed. When a pre-
ICU admission SCr is not available, RIFLE group suggests






urvival curve post cardiac surgery in patients with no acute kidney
ne) and AKI with decreased urine output (UO, dotted green line)
Table 4 Multivariate binary logistic regression of AKI
development according to perioperative factors
OR 95 % CI p-value
Age (years) 1.02 1.00 - 1.04 0.11
Gender (Female vs Male) 0.91 0.52 - 1.59 0.73
BMI (kg/m2) 1.12 1.06 - 1.18 < 0.001
Hypertension (Yes vs No) 0.75 0.44 - 1.28 0.28
COPD (Yes vs No) 1.18 0.67 - 2.09 0.56
Angina pectoris (Yes vs No) 0.70 0.64 - 1.77 0.80
MI previous surgery (Yes vs No) 0.74 0.44 - 1.27 0.28
Diabetes mellitus (Yes vs No) 1.11 0.64 - 1.91 0.72
Emergency (Yes vs No) 0.39 0.09 - 1.72 0.21
Preoperative GFR (mL/min.) 0.98 0.97 - 0.99 0.004
Preoperative hemoglobin (g/dL) 0.02 0.87 - 1.19 0.84
LVEF <60 % (Yes vs No) 1.01 0.60 - 1.71 0.97
Surgical delay (days) 1.00 1.00 - 1.01 0.47
Type of surgery:
Valve (vs CABG) 1.56 0.70 - 3.51 0.28
Valve and CABG (vs CABG) 10.3 3.11 - 33.9 < 0.001
CPB time (min.)* 1.01 1.00 - 1.02 0.17
Aortic cross clamp time (min.)* 0.99 0.96 - 1.01 0.23
Nadir hematocrit (%) 1.01 0.94 - 1.08 0.79
Nadir MAP during surgery (mmHg) 0.99 0.96 - 1.01 0.36
OR: odds ratio ± 95 % confidence interval; BMI: body mass index; COPD:
chronic obstructive pulmonary disease; MI: myocardial infarction; GFR:
glomerular filtration rate; LVEF: left ventricular ejection fraction; Surgical delay:
delay between diagnostic coronarography and surgery; CABG: coronary artery
bypass graft with cardiopulmonary bypass; Valve surgery: aortic valve
replacement or mitral valve repair/replacement surgery; Valve and CABG: aortic
valve replacement or mitral valve repair/replacement surgery combined with
coronary artery bypass graft; CPB: cardiopulmonary bypass; MAP: mean
arterial pressure; *, n=385
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have been associated with both over- or under-diagnosis of
AKI [12, 13]. Here, baseline SCr systematically corre-
sponded with its value 7 days before surgery. Patients de-
veloping AKISCr showed a significantly higher preoperative
morbidity, including hypertension, COPD, CKD and an-
aemia, than AKIUO patients (Table 2). Moreover, 1-year
mortality rate was significantly higher in the case of AKISCr
compared to AKIUO (Fig. 1). Systematic reviews investigat-
ing the validity of RIFLE classification in general ICU pa-
tients concluded that the mortality risk was higher in the
absence of UO criterion in the AKI definition [14, 15]. Still,
discarding the UO criterion has been suggested to delay
the diagnosis of AKI, thereby increasing the mortality in
general ICU patients [11]. In the particular settings of pa-
tients undergoing cardiac surgery, oliguria has also been
associated with an increased incidence of AKI, but with a
reduced discriminant utility for mortality in comparison to
elevated SCr [10, 16]. As a whole, the inclusion of UOconsensus criterion causes a questionable impact on the
overestimated incidence of AKI after cardiac surgery.
The pathophysiology of postoperative AKI is multifac-
torial [17]. In our cohort, patients developing post sur-
gery AKI were older and more fragile according to the
Parsonnet and EuroSCORE1 scores, and presented with
a higher BMI. Furthermore, increased BMI is significantly
associated with DM (29.0 [25.8 - 31.6] vs 25.7 [23.1 -
28.3], p < 0.001) and hypertension (26.4 [23.9 - 29.9] vs
25.7 [23.0 - 27.8], p < 0.02). These risk factors were further
highlighted by our multivariate model (Table 4). Pre-
operative CKD reflected by a lower GFR before surgery
was also associated with an increased risk for AKI. We es-
timated the pre-operative GFR using the MDRD formula
based on serum creatinine concentration 7 days before
surgery [18]. Most patients (76.7 %) showed a GFR within
the normal range, i.e. > 60 ml/min. Patients presenting
with impaired kidney function before surgery were signifi-
cantly older (74 [68 - 78] years) than patients with GFR >
60 mL/min (66 [59 - 74] years, p < 0.001). This represents
a selection bias. Indeed, given the impact of age in the
multivariate logistical regression Parsonnet model, the
predicted mortality rate at 30 days post surgery was
higher in the CKD group compared to the rest of the
cohort. The same pattern was observed with the logis-
tical model EuroSCORE1 [5]. Similarly, we observed a
lower 1-year survival probability in patients with a pre-
operative GFR <60 mL/min [19].
The type and complexity of cardiac surgery was identi-
fied as an independent predictor of post-operative AKI
upon our multivariate model (Table 3). At our institu-
tion, the choice between Off-pump and On-pump pro-
cedures essentially depends on the technical feasibility of
myocardial revascularisation on the basis of coronarogra-
phy images. In the present cohort, the types of surgeries,
with or without CPB, are not distributed homogeneously,
with more patients with normal renal function (15.3 %)
being operated on using the Off-pump technique com-
pared to CKD patients (5.83 %). Still, we did not observe a
significantly higher incidence of AKI in On-pump versus
Off-pump groups, in contrast to previous reports [20–22].
Patients with normal pre-operative renal function were
mostly operated for isolated CABG, whereas only a mi-
nority (10.0 %) underwent combined surgery. Conversely,
the distribution of surgery types appears more balanced
in the CKD group, with 39.8 % of patients operated for
CABG or isolated valve and 20.4 % for combined sur-
gery. Such an imbalance between non-CKD and CKD
patients may represent an additional selection bias in
our analysis since the type of surgery influences the dur-
ation of aortic clamping and CPB, which in turn may
favor AKI development.
In the present cohort, post-operative AKI was associ-
ated with a significantly longer stay in the ICU, with no
Lagny et al. BMC Nephrology  (2015) 16:76 Page 8 of 9impact on the entire in-hospital period. Moreover, the
ICU period significantly increased with the degree of AKI
severity based on the RIFLE stages. Elevation of SCr ap-
peared to be associated with a prolonged ICU stay in com-
parison to UO, although this observation did not reach
statistical significance (p = 0.07). Requirement for RRT was
associated with a dramatic increase in the in-hospital mor-
tality (75.5 %), as was previously reported [23–25].
The present study has several limitations, including its
retrospective and monocentric design with a limited num-
ber of patients. Secondly, the majority of surgical interven-
tions were planned (97.3 %), which limits the extension of
the observations to emergency surgeries. Indeed, the need
for nephrotoxic contrast medium at the time of preopera-
tive coronarography may precipitate AKI development in
cases of early cardiac surgery [26, 27]. Thirdly, the priming
solution of CPB circuit most often consists of Volulyte
6 % (4th generation balanced hydroxyethyl starch). Re-
cently, the use of such a starch has been associated with
an increased incidence of AKI, as well as with postopera-
tive bleeding [28]. Volulyte 6 % solution was chosen for
CPB priming in order to reduce the risk for anaphylactoid
shocks observed with some colloids or gelatins. New gen-
eration starches appear to be less nephrotoxic, provided
that the perfusion is not extended beyond 24 h [29–31].
The optimal priming solution for CPB circuits remains a
matter of debate.Conclusions
The use of the conventional RIFLE classification in a co-
hort of 443 patients undergoing cardiac surgery found
an incidence of AKI reaching 50 %. When each RIFLE cri-
terion was considered individually, a significant discrep-
ancy was found between AKISCr and AKIUO regarding
AKI incidence and outcomes. AKISCr most often occurs in
patients with a high-risk pre-operative profile, and is asso-
ciated with an increased 1-year mortality compared to
AKIUO. In line with previous reports, our present study
urges the need for appropriately powered multi-centric
follow-up trials to clarify the actual utility of UO as a cri-
terion for AKI diagnosis and management in patients
undergoing cardiac surgery.Abbreviations
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